Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph J Dajcs

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Investigative Ophthalmology & Visual Science|December 31, 2002
Phospholipase A2 activity in normal and Staphylococcus aureus-infected rabbit eyesDalia O Girgis, Joseph J Dajcs, Richard J O'Callaghan
Ocular Immunology and Inflammation|October 21, 2003
Host defense against bacterial keratitisRichard J O'Callaghan, Dalia O Girgis, Joseph J Dajcs, et al.
DNA and Cell Biology|August 9, 2002
Corneal virulence of Staphylococcus aureus in an experimental model of keratitisJoseph J Dajcs, Brett A Thibodeaux, Dalia O Girgis, et al.
Survey of Ophthalmology|November 1, 2005
In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinoloneDavid W Stroman, Joseph J Dajcs, Gale A Cupp, et al.
Current Eye Research|March 15, 2006
The effectiveness of lysostaphin therapy for experimental coagulase-negative Staphylococcus endophthalmitisClare C McCormick, Joseph J Dajcs, Julian M Reed, et al.
Medical Microbiology and Immunology|November 25, 2003
Calcium and magnesium enhance the production of Pseudomonas aeruginosa protease IV, a corneal virulence factorMary E Marquart, Joseph J Dajcs, Armando R Caballero, et al.
International Journal of Systematic and Evolutionary Microbiology|April 6, 2006
Pseudomonas otitidis sp. nov., isolated from patients with otic infectionsLinda L Clark, Joseph J Dajcs, Celeste H McLean, et al.
Advances in Therapy|February 23, 2010
Comparison of fluoroquinolone kinetics of kill in susceptible and resistant gram-positive conjunctival pathogensPeter A D'Arienzo, Rudolph S Wagner, Tiffany Jamison, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2004
Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitisJoseph J Dajcs, Brett A Thibodeaux, Mary E Marquart, et al.
Ocular Immunology and Inflammation|July 16, 2005
Pseudomonas aeruginosa protease IV: a corneal virulence factor of low immunogenicityBrett A Thibodeaux, Armando R Caballero, Joseph J Dajcs, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Investigative Ophthalmology & Visual Science|December 31, 2002
Phospholipase A2 activity in normal and Staphylococcus aureus-infected rabbit eyesDalia O Girgis, Joseph J Dajcs, Richard J O'Callaghan
Ocular Immunology and Inflammation|October 21, 2003
Host defense against bacterial keratitisRichard J O'Callaghan, Dalia O Girgis, Joseph J Dajcs, et al.
DNA and Cell Biology|August 9, 2002
Corneal virulence of Staphylococcus aureus in an experimental model of keratitisJoseph J Dajcs, Brett A Thibodeaux, Dalia O Girgis, et al.
Survey of Ophthalmology|November 1, 2005
In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinoloneDavid W Stroman, Joseph J Dajcs, Gale A Cupp, et al.
Current Eye Research|March 15, 2006
The effectiveness of lysostaphin therapy for experimental coagulase-negative Staphylococcus endophthalmitisClare C McCormick, Joseph J Dajcs, Julian M Reed, et al.
Medical Microbiology and Immunology|November 25, 2003
Calcium and magnesium enhance the production of Pseudomonas aeruginosa protease IV, a corneal virulence factorMary E Marquart, Joseph J Dajcs, Armando R Caballero, et al.
International Journal of Systematic and Evolutionary Microbiology|April 6, 2006
Pseudomonas otitidis sp. nov., isolated from patients with otic infectionsLinda L Clark, Joseph J Dajcs, Celeste H McLean, et al.
Advances in Therapy|February 23, 2010
Comparison of fluoroquinolone kinetics of kill in susceptible and resistant gram-positive conjunctival pathogensPeter A D'Arienzo, Rudolph S Wagner, Tiffany Jamison, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2004
Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitisJoseph J Dajcs, Brett A Thibodeaux, Mary E Marquart, et al.
Ocular Immunology and Inflammation|July 16, 2005
Pseudomonas aeruginosa protease IV: a corneal virulence factor of low immunogenicityBrett A Thibodeaux, Armando R Caballero, Joseph J Dajcs, et al.
Pageof 2